A prospective survey of current prostate biopsy practices among oncological urologists

Canadian Journal of Urology

Volumn 17, Issue 2, 2010, Pages 5071-5076

  Brewster, Simon ^a   Türkeri, Levent ^b   Brausi, Maurizio ^c   Ravery, Vincent ^d   Djavan, Bob ^e  

^a CHURCHILL HOSPITAL   (United Kingdom)

^b MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c AUSL Modena   (Italy)

^d BICHAT HOSPITAL   (France)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Prostate biopsy; Prostate cancer; Transrectal ultrasound

Indexed keywords

ANTIBIOTIC PROPHYLAXIS; ARTICLE; CLINICAL PRACTICE; EUROPE; HUMAN; LOCAL ANESTHESIA; MALE; MEDICAL SOCIETY; METHODOLOGY; NEEDLE BIOPSY; PATHOLOGY; PRACTICE GUIDELINE; PROSPECTIVE STUDY; PROSTATE TUMOR; QUESTIONNAIRE; STATISTICS; UROLOGY;

ANESTHESIA, LOCAL; ANTIBIOTIC PROPHYLAXIS; BIOPSY, NEEDLE; EUROPE; GUIDELINE ADHERENCE; HUMANS; MALE; PHYSICIAN'S PRACTICE PATTERNS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUESTIONNAIRES; SOCIETIES, MEDICAL; UROLOGY;

EID: 77956216417     PISSN: 11959479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Torp-Pedersen ST, Lee F. Transrectal biopsy of the prostate guided by transrectal ultrasound. Urol Clin North Am 1989; 16(4):703-712.
2. Presti JC Jr, Chang JJ, Bhargava V, Shinohara K. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. J Urol 2000; 163(1):163-166.
3. Emiliozzi P, Scarpone P, DePaula F, Pizzo M, Federico G, Pansadoro A, Martini M, Pansadoro V. The incidence of prostate cancer in men with prostate specifi c antigen greater than 4.0 ng/ml: a randomized study of 6 versus 12 core transperineal prostate biopsy. J Urol 2004;171(1):197-199.
4. von Knobloch R, Weber J, Varga Z, Feiber H, Heidenreich A, Hofmann R. Bilateral fi ne-needle administered local anaesthetic nerve block for pain control during TRUS-guided multi-core prostate biopsy: a prospective randomised trial. Eur Urol 2002; 41(5):508-514.
5. Soloway MS. Do unto others--why I would want anesthesia for my prostate biopsy. Urology 2003;62(6):973-975.
6. Djavan B, Margreiter M. Biopsy standards for detection of prostate cancer. World J Urol 2007;25(1):11-17.
7. Brewster SF, MacGowan AP, Gingell JC. Antimicrobial prophylaxis for transrectal prostatic biopsy: a prospective randomized trial of cefuroxime versus piperacillin/tazobactam. Br J Urol 1995;76(3):351-354.
8. Remzi M, Fong YK, Dobrovits M, Anagnostou T, Seitz C, Waldert M, Harik M, Marihart S, Marberger M, Djavan B. The Vienna nomogram: validation of a novel biopsy strategy defi ning the optimal number of cores based on patient age and total prostate volume. J Urol 2005;174(4 Pt 1):1256-1261.
9. Merrick GS, Taubenslag W, Andreini H, Brammer S, Butler WM, Adamovich E, Allen Z, Anderson R, Wallner KE. The morbidity of transperineal template-guided prostate mapping biopsy. BJU Int 2008;101(12):1524-1529.
10. Zigeuner R, Schips L, Lipsky K, Auprich M, Salfeliner M, Rehak P, Pummer K, Hubmer G. Detection of prostate cancer by TURP or open surgery in patients with previously negative transrectal prostate biopsies. Urology 2003;62(5):883-887.
11. European Association of Urology Guidelines 2009 may be viewed and downloaded at the following: http://www.uroweb.org/nc/professional-resources/guidelines/online/
12. Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Lucia MS, Parnes HL, Minasian LM, Ford LG, Lippman SM, Crawford ED, Crowley JJ, Coltman CA Jr. Prevalence of prostate cancer among men with a prostate-specifi c antigen level < or =4.0 ng per millilter.N Engl J Med 2004;350(22):2239-2246.
13. Moore CK, Karikehalli S, Nazeer T, Fisher HA, Kaufman RP Jr, Mian BM. Prognostic significance of high grade prostatic intraepithelial neoplasia and atypical small acinar proliferation in the contemporary era. J Urol 2005;173(1):70-72.
14. Pelzer AE, Bektic J, Berger AP, Halpern EJ, Koppelstatter F, Klauser A, Rehder P, Horninger W, Bartsch G, Frauscher F. Are transition zone biopsies still necessary to improve prostate cancer detection? Results from the Tyrol screening project. Eur Urol 2005;48(6):916-921.
15. Adamakis I, Mitropoulos D, Haritopoulos K, Alamanis C, Stravodimos K, Giannopoulos A. Pain during transrectal ultrasonography guided prostate biopsy: a randomized prospective trial comparing periprostatic infiltration with lidocaine with the intrarectal instillation of lidocaine-prilocain cream. World J Urol 2004;22(4):281-284.
16. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293(17):2126-2130.
17. Butler MJ, Eccleston D, Clark DJ, Ajani AE, Andrianopoulos N, Brennan A, New G, Black A, Szto G, Reid CM, Yan BP, Shaw JA, Dart AM, Duffy SJ; Melbourne Interventional Group. The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stents. Am Heart J 2009;157(5):899-907.
18. Carlsson J, von Wagenheim B, Linder R, Anwari TM, Qvist J, Petersson I, Magounakis T, Lagerqvist B. Is late stent thrombosis in drug-eluting stents a real clinical issue? A single-center experience and review of the literature. Clin Res Cardiol 2007; 96(2):86-93.